Highlights Cerus Corporation

Equities

CERS

US1570851014

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.71 ^USD	+0.59%		+1.79%	-20.83%

Apr. 12	Craig-Hallum Starts Cerus With Buy Rating, $5 Price Target	MT
Mar. 26	Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets - Doubling Previous Shelf Life	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets - Doubling Previous Shelf Life	Mar. 26	CI
Cerus Says Intercept Blood System Meets Non-Inferiority Goal in Phase 3 Study; Shares Rise	Mar. 19	MT
Cerus Shares Rise on Positive Results for Intercept Blood Cells Trial	Mar. 19	DJ
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients	Mar. 19	CI
Cerus Reiterates Full Year 2024 Product Revenue Guidance of $172-$175 Million	Mar. 05	MT
Earnings Flash (CERS) CERUS CORPORATION Reports Q4 Revenue $53.3M, vs. Street Est of $52M	Mar. 05	MT
Cerus Corporation Reiterates Product Revenue Guidance for the Full Year 2024	Mar. 05	CI
Cerus Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 05	CI
Cerus Corporation Provides Revenue Guidance for the Fiscal Year 2024	Jan. 08	CI
Cerus Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Earnings Flash (CERS) CERUS CORPORATION Reports Q3 Revenue $47.3M, vs. Street Est of $42.8M	Nov. 02	MT
Cerus Corporation Provides Product Revenue Guidance for the Full-Year 2023	Nov. 02	CI
Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on Its Digital Marketplace	Nov. 01	CI
Cerus Corporation Revises Revenue Guidance for the Year 2023	23-08-02	CI
Cerus Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Earnings Flash (CERS) CERUS CORPORATION Posts Q2 Revenue $47.7M, vs. Street Est of $41.8M	23-08-02	MT
Cerus Corporation Announces Follow-On Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate	23-06-05	CI
Cerus Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Earnings Flash (CERS) CERUS CORPORATION Posts Q1 Revenue $38.5M, vs. Street Est of $37M	23-05-04	MT
Cerus Corporation Reiterates Revenue Guidance for the Year 2023	23-05-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cerus Corporation

Equities

CERS

US1570851014

Highlights

Filters